BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 12610180)

  • 1. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
    Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
    J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial genomic instability in colorectal cancer: no correlation to nuclear microsatellite instability and allelic deletion of hMSH2, hMLH1, and p53 genes, but prediction of better survival for Dukes' stage C disease.
    Tsai MH; Fang WH; Lin SW; Yen SJ; Chou SJ; Yang YC
    Ann Surg Oncol; 2009 Oct; 16(10):2918-25. PubMed ID: 19582509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic losses of 17p, 5q, and 18q loci in diploid and aneuploid populations of multiploid colorectal carcinomas.
    Sugai T; Habano W; Nakamura S; Sato H; Uesugi N; Orii S; Itoh C; Katoh R
    Hum Pathol; 2000 Aug; 31(8):925-30. PubMed ID: 10987252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
    Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H
    Cancer; 2000 Jun; 88(12):2661-7. PubMed ID: 10870047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.
    Choi SW; Lee KJ; Bae YA; Min KO; Kwon MS; Kim KM; Rhyu MG
    Clin Cancer Res; 2002 Jul; 8(7):2311-22. PubMed ID: 12114436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
    Halling KC; French AJ; McDonnell SK; Burgart LJ; Schaid DJ; Peterson BJ; Moon-Tasson L; Mahoney MR; Sargent DJ; O'Connell MJ; Witzig TE; Farr GH; Goldberg RM; Thibodeau SN
    J Natl Cancer Inst; 1999 Aug; 91(15):1295-303. PubMed ID: 10433618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
    Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K
    Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer.
    de Manzoni G; Tomezzoli A; Di Leo A; Moore PS; Talamini G; Scarpa A
    Br J Surg; 2001 Mar; 88(3):419-25. PubMed ID: 11260110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer.
    Bisgaard ML; Jäger AC; Dalgaard P; Søndergaard JO; Rehfeld JF; Nielsen FC
    Scand J Gastroenterol; 2001 Apr; 36(4):405-9. PubMed ID: 11336166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
    Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
    Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
    Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
    BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer.
    De Angelis PM; Stokke T; Beigi M; Mjåland O; Clausen OP
    Int J Colorectal Dis; 2001 Feb; 16(1):38-45. PubMed ID: 11317696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
    Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
    Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
    Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
    N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.
    Carethers JM; Hawn MT; Greenson JK; Hitchcock CL; Boland CR
    Gastroenterology; 1998 Jun; 114(6):1188-95. PubMed ID: 9609755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of genetic changes in progression of colorectal cancer].
    Kuroda K; Watatani M; Yoshida T; Ieda S; Shindo K; Yasutomi M
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():164-8. PubMed ID: 8678562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis?
    O'Connell MJ; Schaid DJ; Ganju V; Cunningham J; Kovach JS; Thibodeau SN
    Cancer; 1992 Sep; 70(6 Suppl):1732-9. PubMed ID: 1516028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.